DE10206849A1 - Phenalenon-Derivate, Verfahren zur Herstellung und Verwendung derselben - Google Patents

Phenalenon-Derivate, Verfahren zur Herstellung und Verwendung derselben Download PDF

Info

Publication number
DE10206849A1
DE10206849A1 DE10206849A DE10206849A DE10206849A1 DE 10206849 A1 DE10206849 A1 DE 10206849A1 DE 10206849 A DE10206849 A DE 10206849A DE 10206849 A DE10206849 A DE 10206849A DE 10206849 A1 DE10206849 A1 DE 10206849A1
Authority
DE
Germany
Prior art keywords
formula
compound
alkyl
alkenyl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10206849A
Other languages
German (de)
English (en)
Inventor
Laszlo Dr. Vertesy
Michael Dr. Kurz
Ziyu Dr. Li
Luigi Dr. Toti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Priority to DE10206849A priority Critical patent/DE10206849A1/de
Priority to EP03739452A priority patent/EP1478731A1/de
Priority to AU2003210205A priority patent/AU2003210205B2/en
Priority to JP2003568061A priority patent/JP2005517710A/ja
Priority to MXPA04007918A priority patent/MXPA04007918A/es
Priority to PCT/EP2003/001060 priority patent/WO2003068946A1/de
Priority to BR0307733-0A priority patent/BR0307733A/pt
Priority to CA002476618A priority patent/CA2476618A1/en
Priority to PE2003000139A priority patent/PE20030904A1/es
Priority to ARP030100503A priority patent/AR038524A1/es
Priority to US10/367,545 priority patent/US7253206B2/en
Publication of DE10206849A1 publication Critical patent/DE10206849A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92—Naphthofurans; Hydrogenated naphthofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/80—Penicillium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE10206849A 2002-02-18 2002-02-18 Phenalenon-Derivate, Verfahren zur Herstellung und Verwendung derselben Withdrawn DE10206849A1 (de)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DE10206849A DE10206849A1 (de) 2002-02-18 2002-02-18 Phenalenon-Derivate, Verfahren zur Herstellung und Verwendung derselben
EP03739452A EP1478731A1 (de) 2002-02-18 2003-02-04 Phenalenon-derivative, verfahren zur herstellung und verwendung derselben
AU2003210205A AU2003210205B2 (en) 2002-02-18 2003-02-04 Phenalenone derivatives, method for the production thereof and use of the same
JP2003568061A JP2005517710A (ja) 2002-02-18 2003-02-04 フェナレノン誘導体、その製造方法および使用
MXPA04007918A MXPA04007918A (es) 2002-02-18 2003-02-04 Derivados de fenalenona, procedimientos para su preparacion y utilizacion de los mismos.
PCT/EP2003/001060 WO2003068946A1 (de) 2002-02-18 2003-02-04 Phenalenon-derivative, verfahren zur herstellung und verwendung derselben
BR0307733-0A BR0307733A (pt) 2002-02-18 2003-02-04 Derivados de fenalenona, processo para sua preparação e seu uso
CA002476618A CA2476618A1 (en) 2002-02-18 2003-02-04 Phenalenone derivatives, method for the production thereof and use of the same
PE2003000139A PE20030904A1 (es) 2002-02-18 2003-02-06 Derivados de fenalenona, procedimiento para su preparacion y utilizacion de los mismos
ARP030100503A AR038524A1 (es) 2002-02-18 2003-02-14 Derivados de fenalenona, procedimiento para su preparacion y utilizacion de los mismos
US10/367,545 US7253206B2 (en) 2002-02-18 2003-02-14 Phenalenone derivatives, processes for preparation and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10206849A DE10206849A1 (de) 2002-02-18 2002-02-18 Phenalenon-Derivate, Verfahren zur Herstellung und Verwendung derselben

Publications (1)

Publication Number Publication Date
DE10206849A1 true DE10206849A1 (de) 2005-07-28

Family

ID=27674733

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10206849A Withdrawn DE10206849A1 (de) 2002-02-18 2002-02-18 Phenalenon-Derivate, Verfahren zur Herstellung und Verwendung derselben

Country Status (10)

Country Link
EP (1) EP1478731A1 (https=)
JP (1) JP2005517710A (https=)
AR (1) AR038524A1 (https=)
AU (1) AU2003210205B2 (https=)
BR (1) BR0307733A (https=)
CA (1) CA2476618A1 (https=)
DE (1) DE10206849A1 (https=)
MX (1) MXPA04007918A (https=)
PE (1) PE20030904A1 (https=)
WO (1) WO2003068946A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9376415B2 (en) 2009-03-30 2016-06-28 Nippon Suisan Kaisha, Ltd. Tricyclic condensed heterocyclic compound, process of producing same, and use thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011009899A2 (en) * 2009-07-22 2011-01-27 Instituto Biomar, S.A. Phenalenones as antitumoral agents
FR2987622B1 (fr) * 2012-03-02 2016-01-15 Centre Nat Rech Scient Composes oxo-phenalenes, leur preparation et utilisation dans les domaines des materiaux et therapeutique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2812510B2 (ja) * 1989-10-06 1998-10-22 日清製油株式会社 アトロベネチンの用途
EP1151295A4 (en) * 1999-02-01 2005-03-30 Cytovia Inc METHOD FOR IDENTIFYING THERAPEUTICALLY EFFECTIVE ANTINEOPLASTIC SUBSTANCES USING CULTURED CELLS WITH INTACT CELL MEMBRANES AND RELATED PRODUCTS THEREOF

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9376415B2 (en) 2009-03-30 2016-06-28 Nippon Suisan Kaisha, Ltd. Tricyclic condensed heterocyclic compound, process of producing same, and use thereof

Also Published As

Publication number Publication date
MXPA04007918A (es) 2004-11-26
AR038524A1 (es) 2005-01-19
JP2005517710A (ja) 2005-06-16
AU2003210205B2 (en) 2007-06-14
BR0307733A (pt) 2005-01-25
PE20030904A1 (es) 2003-11-18
CA2476618A1 (en) 2003-08-21
AU2003210205A1 (en) 2003-09-04
WO2003068946A1 (de) 2003-08-21
EP1478731A1 (de) 2004-11-24

Similar Documents

Publication Publication Date Title
DE3750495T2 (de) Milbemycin-Derivate mit parasitenabtötender Aktivität, ein Verfahren zu ihrer Herstellung und die sie enthaltenden Zusammensetzungen.
DE19745583A1 (de) Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben
DE68903907T2 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
EP1689731B1 (de) 2-phenyl-benzofuran-derivate, verfahren zur ihrer herstellung und ihre verwendung
EP1280812B1 (de) Cyclipostine, verfahren zu ihrer herstellung und verwendung derselben
EP1341758B1 (de) Coniosetin und derivate davon, verfahren zur herstellung und verwendung derselben
DE10206849A1 (de) Phenalenon-Derivate, Verfahren zur Herstellung und Verwendung derselben
EP0829487B1 (de) Neue Polyenantibiotika 3874 H1 bis H6, Verfahren zu ihrer Herstellung und Verwendung
US7253206B2 (en) Phenalenone derivatives, processes for preparation and use thereof
EP1472240B1 (de) Drechsleranol-derivate, verfahren zu deren herstellung und deren verwendung
EP1474440B1 (de) Coniosulfide und deren derivate, verfahren zur ihrer herstellung und verwendung als arzneimittel
EP1404663B1 (de) Eurotinone und derivate davon, verfahren zu ihrer herstellung und verwendung derselben
EP1519909B1 (de) Polyencarbonsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung
EP0848064B1 (de) Neues Antibiotikum, Feglymycin, Verfahren zu seiner Herstellung und Verwendung
DE10111682A1 (de) Caloporosid-Derivate, Verfahren zu deren Herstellung und deren Verwendung
EP1448522B1 (de) Gabusectin-derivate, verfahren zur deren herstellung und deren verwendung
EP1125944A1 (de) Pluraflavine und Derivate davon, Verfahren zu ihrer Herstellung und Verwendung derselben
DE4231451A1 (de) Waraterpole, neue terpenanaloge Metabolite aus Penicillium sp. mit pharmakologischer Wirkung, ein Verfahren zu ihrer Herstellung und ihre Verwendung
DE4225284A1 (de) Clonostachydiol und Helmidiol, neue Makrodiolide mit pharmakologischer Wirkung, ein Verfahren zu ihrer Herstellung und ihre Verwendung
DE19611366A1 (de) Neue Naturstoffe der Hyphodermine und chemische Derivate
DE4303512A1 (de) Aspinonen, ein Metabolit aus Aspergillus sp., und chemische Derivate mit pharmakologischer Wirkung, ein Verfahren zur Herstellung und Verwendung derselben

Legal Events

Date Code Title Description
OR8 Request for search as to paragraph 43 lit. 1 sentence 1 patent law
8105 Search report available
8127 New person/name/address of the applicant

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, 65929 FRANKFURT,

8130 Withdrawal